jiac335.pdf
768.3 KB
Oxford Journal of Infectious Diseases (December issue Drop 2 of 5)
1) Evaluation of the Homeless Management Information System for COVID-19 Surveillance Among People Experiencing Homelessness
2) COVID-19 Vaccination Coverage Among People Experiencing Homelessness in a Highly Vaccinated Midwest County—Dane County, Wisconsin, 2021
3) Communicating Effectively With People Experiencing Homelessness to Prevent Infectious Diseases
4) Engaging Same-Day Peer Ambassadors to Increase Coronavirus Disease 2019 Vaccination Among People Experiencing Unsheltered Homelessness in Los Angeles County: A Hybrid Feasibility-Evaluation Study
5) HIV Treatment Outcomes in POP-UP: Drop-in HIV Primary Care Model for People Experiencing Homelessness
6) The Impact of Supportive Housing on Liver-Related Outcomes Among Persons With Hepatitis C Virus Infection
7) Public Health and Homelessness: A Framework
1) Evaluation of the Homeless Management Information System for COVID-19 Surveillance Among People Experiencing Homelessness
2) COVID-19 Vaccination Coverage Among People Experiencing Homelessness in a Highly Vaccinated Midwest County—Dane County, Wisconsin, 2021
3) Communicating Effectively With People Experiencing Homelessness to Prevent Infectious Diseases
4) Engaging Same-Day Peer Ambassadors to Increase Coronavirus Disease 2019 Vaccination Among People Experiencing Unsheltered Homelessness in Los Angeles County: A Hybrid Feasibility-Evaluation Study
5) HIV Treatment Outcomes in POP-UP: Drop-in HIV Primary Care Model for People Experiencing Homelessness
6) The Impact of Supportive Housing on Liver-Related Outcomes Among Persons With Hepatitis C Virus Infection
7) Public Health and Homelessness: A Framework
jiac347.pdf
284.8 KB
Oxford Journal of Infectious Diseases (December issue Drop 3 of 5)
1) Bebtelovimab in the Real World: Promise and Fulfillment
2) Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During SARS Cov 2 BA.2 Omicron Epoch
3) Neutralizing Immunity Induced Against the Omicron BA.1 and BA.2 Variants in Vaccine Breakthrough Infections
4) SARS-CoV-2 Virus Dynamics in Recently Infected People—Data From a Household Transmission Study
5) Understanding Early Pandemic Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Medical Center by Incorporating Public Sequencing Databases to Mitigate Bias
1) Bebtelovimab in the Real World: Promise and Fulfillment
2) Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During SARS Cov 2 BA.2 Omicron Epoch
3) Neutralizing Immunity Induced Against the Omicron BA.1 and BA.2 Variants in Vaccine Breakthrough Infections
4) SARS-CoV-2 Virus Dynamics in Recently Infected People—Data From a Household Transmission Study
5) Understanding Early Pandemic Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Medical Center by Incorporating Public Sequencing Databases to Mitigate Bias
jiac247.pdf
409.3 KB
Oxford Journal of Infectious Diseases (December issue Drop 4 of 5)
1) Vaccination After SARS-CoV-2 Infection Increased Antibody Avidity Against the Omicron Variant Compared to Vaccination Alone
2) Omicron Breakthrough Infection After Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response
3) Viral Load Dynamics in SARS-CoV-2 Omicron Breakthrough Infections
4) Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Shedding and Predictors of Viral Culture Positivity on Vaccinated Healthcare Workers With Mild Coronavirus Disease 2019
5) Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial
1) Vaccination After SARS-CoV-2 Infection Increased Antibody Avidity Against the Omicron Variant Compared to Vaccination Alone
2) Omicron Breakthrough Infection After Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response
3) Viral Load Dynamics in SARS-CoV-2 Omicron Breakthrough Infections
4) Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Shedding and Predictors of Viral Culture Positivity on Vaccinated Healthcare Workers With Mild Coronavirus Disease 2019
5) Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial
jiac198.pdf
941 KB
Oxford Journal of Infectious Diseases (December issue Drop 5 of 5)
1) Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019
2) Clinical and In Vitro Evidence Favoring Immunoglobulin Treatment of a Chronic Norovirus Infection in a Patient With Common Variable Immunodeficiency
3) Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
4) Dynamic Immune Profile in French Toxoplasmosis Patients
5) A Composite Recombinant Salivary Proteins Biomarker for Phlebotomus argentipes Provides a Surveillance Tool Postelimination of Visceral Leishmaniasis in India
1) Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019
2) Clinical and In Vitro Evidence Favoring Immunoglobulin Treatment of a Chronic Norovirus Infection in a Patient With Common Variable Immunodeficiency
3) Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
4) Dynamic Immune Profile in French Toxoplasmosis Patients
5) A Composite Recombinant Salivary Proteins Biomarker for Phlebotomus argentipes Provides a Surveillance Tool Postelimination of Visceral Leishmaniasis in India
👍1